The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of consolidation amrubicin after concurrent chemoradiotherapy for patients with limited-stage small cell lung cancer.
 
Hironori Yoshida
No Relationships to Disclose
 
Young Hak Kim
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Hiroaki Ozasa
No Relationships to Disclose
 
Yuichi Sakamori
No Relationships to Disclose
 
Takashi Nishimura
No Relationships to Disclose
 
Keisuke Tomii
No Relationships to Disclose
 
Tadashi Mio
No Relationships to Disclose
 
Toyohiro Hirai
No Relationships to Disclose